Authors


Deema Abdelrahman, PharmBSc, BCIDP

Latest:

Antimicrobial Stewardship: How to Extend a Solid Handshake

In the latest column from SIDP, handshake stewardship prioritizes face-to-face communication between frontline providers to enable feedback to assess the appropriateness of prescribed antimicrobials.


Nicole Bradley, PharmD, BCPS, BCIDP

Latest:

Shifting to Shorter Courses of Antibiotic Therapy for Common Pediatric Infections

In the latest SIDP column, two clinicians provide information on recent studies and guidelines directed at antibiotic durations in this patient population.


Stephen Pagkalinawan, MD

Latest:

A Case of Hemophagocytic Lymphohistiocytosis Secondary to Cytomegalovirus Infection

There have been sporadic cases Hemophagocytic Lymphohistiocytosis, associated with Cytomegalovirus Infection infection, suggesting that CMV may cause clinically significant disease beyond mononucleosis in immunocompetent individuals.



Esther Y. Bae, PharmD, BCIDP

Latest:

Impact of Inpatient Pharmacist Review of Discharge Antibiotics

A food for thought as an ambulatory antibiotic stewardship initiative.


Ali Hassan, PharmD

Latest:

Considerations for Antimicrobial Stewardship While Optimizing Therapy for a Patient With HIV

Here is a case study involving a patient with the virus and the clinical approach in thinking about appropriate treatment while keeping stewardship in mind.



Freda Kreier

Latest:

Internal Tremors: Adding to the List of Long COVID Symptoms

Internal tremors are a newly recognized and troubling symptom of Long COVID, experienced by over one-third of participants in a Yale-based study


Seung Ha, PharmD

Latest:

Discussing Outpatient COVID-19 Treatments

Here is a look at some of the treatment alternatives, which can offer simpler logistics and cost considerations.


Nicholas Rebold, PharmD, BCIDP, AAHIVP, MPH

Latest:

The Role of Rifampin in Bone and Joint Infections

In the latest column from the Society of Infectious Diseases Pharmacists (SIDP), here is a discussion on the use of rifampin as an adjunctive antibiotic treatment for patients with diabetic foot osteomyelitis.


Nicolás Cortés-Penfield, MD

Latest:

Updates and Controversies in Necrotizing Soft Tissue Infections

Changes in microbiology and antimicrobial resistance patterns warrant reevaluation of our current therapies for this condition.


Christian John Lillis

Latest:

The Benefits of Making C diff a Nationally Notifiable Infectious Disease

In the second part of our interview with Christian Lillis, cofounder and CEO of the Peggy Lillis Foundation, he discusses what the passage of the Peggy Lillis Clostridioides difficile Inclusion Act would do for reporting of the infection as well as the potential ancillary effects around antibiotic development and antimicrobial resistance.


Sara Haddad, MD

Latest:

Ruptured Echinococcal Pulmonary Cyst

Here is a review of this specific case.


Daniel Tsang, MD

Latest:

Ruptured Echinococcal Pulmonary Cyst

Here is a review of this specific case.


Rachel Zetts, MS

Latest:

Antibiotic Stewardship Programs Help Curb Superbug Threat by Leveraging Data

The OASIS platform will help outpatient facilities use prescribing data to improve patient care.





Morgan L. Bixby, BS

Latest:

What’s New in 2023 From the CLSI Subcommittee on Antimicrobial Susceptibility Testing

This year's Clinical and Laboratory Standards Institute (CLSI) Subcommittee on Antimicrobial Susceptibility Testing provided updated breakpoints on therapies.


Luke Buxton, DO

Latest:

Nonventilator Hospital-Acquired Pneumonia: Epidemiology, Prevention, and Where It Is Now

The management of hospital-acquired pneumonia requires use of preventive bundles, mitigative of risk factors, and prompt diagnosis with initiation of treatment when highly suspected.


Edward Walsh, MD

Latest:

The Impact of Widespread RSV Vaccination and Quantifying Results

In the fourth and final episode, the clinicians speak of the need for greater uptake of the RSV vaccines, overcoming an "RSV identity crisis," and the potential ancillary benefit of reducing bacterial infections.


Jon Matthew Farber, MD

Latest:

Fluoroquinolone Safe for Treating Severe Refractory M Pneumoniae Pneumonia

Investigators asked the children’s parents about the history of musculoskeletal-related disease, observed the children’s gait, and performed physical examinations.


Steve Mok, PharmD, MBA, BCPS, BCIDP

Latest:

Navigating the Challenges of CMS AUR Reporting Mandates: Penalties, Progress, and Pitfalls

The long-term benefits of antimicrobial use and resistance (AUR) reporting is about improving patient care and combating resistance.


Ian Cook, PharmD

Latest:

Examining the HIV Treatment Pipeline

A review of selected investigational long-active treatment options for HIV.




Madeline King, PharmD

Latest:

Do Antibiotic Adverse Effects Affect Prescribing Practices?

A focus group study reviewed provider practices to learn more about patient management and explore the potential to follow up with clinicians on important takeaways.



Mackenzie Keintz, MD

Latest:

Invasive Nontyphoidal Salmonellosis: An Antimicrobial-Resistant Foe

Salmonella becomes more dangerous as antimicrobial resistance grows. Read about its most common manifestations.


David Pitrak, MD

Latest:

Lessons in Resilience: What HIV Teaches Us About COVID-19

Four lessons learned from the AIDS crisis that can be applied to the fight against our current pandemic.

© 2024 MJH Life Sciences

All rights reserved.